Showing results (541-550 of 640) with videos related to
Sort By:
Pageof 64
Open Forum Infectious Diseases|November 3, 2025
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083Hannah P Moore, Jessica M Fogel, Mark A Marzinke, et al.Blood|November 3, 2022
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapyOliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, et al.Blood Advances|April 15, 2024
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapiesAnna J Howard, Isabel Concepcion, Alice X Wang, et al.Open Forum Infectious Diseases|July 9, 2025
Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 SitesCissy Kityo, Caitlyn McCarthy, Serena P Koenig, et al.JCO Precision Oncology|July 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected CasesNishi Shah, Melissa Suchanek, Astha Thakkar, et al.Blood Cancer Journal|May 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myelomaBruno Almeida Costa, Jessica Flynn, Noriko Nishimura, et al.The Journal of Experimental Medicine|February 9, 2024
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapyLei Wang, Yufeng Xiao, Yuewan Luo, et al.Eclinicalmedicine|December 7, 2022
The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysisLauren L O'Mahoney, Ash Routen, Clare Gillies, et al.Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centersMalin Hultcrantz, Joshua Richter, Cara Rosenbaum, et al.Blood|September 8, 2023
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapiesZhiwei Ang, Luca Paruzzo, Katharina E Hayer, et al.Pageof 64